CAS: 220651-94-5
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Ruplizumab REF: TM-T76825CAS: 220651-94-5 | 95% - 95% | 230,00 €~1.644,00 € | Mié 16 Abr 25 |
 | Ruplizumab REF: 3D-CLA1059CAS: 220651-94-5 | - - - | 1.186,00 €~2.789,00 € | Mar 27 May 25 |
Ruplizumab
CAS:220651-94-5
PF-03732010 is a humanized antibody targeting P-calmodulin with antitumor and antimetastatic activity.
Pureza:
95% - 95%
Forma y color:
Liquid
Ref: TM-T76825
| 1mg | 230,00 € | ||
| 5mg | 602,00 € | ||
| 10mg | 822,00 € | ||
| 25mg | 1.216,00 € | ||
| 50mg | 1.644,00 € |
Entrega estimada en Estados Unidos, el Miércoles 16 de Abril de 2025
Ruplizumab
CAS:220651-94-5
Humanized whole monoclonal antibody targeting CD154; designed to treat rheumatic diseases
Ref: 3D-CLA1059
| 1mg | 1.186,00 € | ||
| 5mg | 2.021,00 € | ||
| 10mg | 2.789,00 € |
Entrega estimada en Estados Unidos, el Martes 27 de Mayo de 2025
